LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

Recruiting now · Not applicable

Conditions studied: Left-sided Pancreatic Cancer

In brief

This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.

Key facts

Study ID

NCT05939063

Run by

Fudan University

People needed

160

Starts

2023-10-01

Expected to finish

2028-08-31

Last updated by the study team

2023-11-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically diagnosed as resectable left-sided pancreatic cancer before surgery.
• Imaging tumor diameter ≤ 4 cm.
• Located ≥ 1cm from the celiac trunk.
• Tumor didn't invade the fascial layer behind the pancreas.
• Be able to comply with research protocol.
• Voluntary participation and signed informed consent.

You may not qualify if…

• Received neoadjuvant therapy.
• Presence of liver or other distant metastasis.
• Multifocal or recurrent disease.
• History of other malignancies.
• Simultaneously participating in other clinical trials.

Where it is running

• Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.